Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues

Journal of Biological Regulators and Homeostatic Agents

Volumn 31, Issue 2, 2017, Pages 263-267

  Conti, P ^a   Caraffa, Al ^b   Kritas, S K ^c   Ronconi, G ^d   Lessiani, G ^e   Toniato, E ^a   Theoharides, T C ^f  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^e Center of Intensive Rehabilitation   (Italy)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokines; Cytokines; Immunity; Inflammation; Mast cell

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 33; INTERLEUKIN 37; CYTOKINE; LEUKOCYTE ANTIGEN; NITRIC OXIDE;

ANTIINFLAMMATORY ACTIVITY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CYTOKINE PRODUCTION; GENE EXPRESSION; GRANULOCYTE; HUMAN; IMMUNE RESPONSE; MAST CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; ADAPTIVE IMMUNITY; ANIMAL; ARTHRITIS; ASTHMA; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION; TH1 CELL;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD; ARTHRITIS; ASTHMA; CYTOKINES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MAST CELLS; NEOPLASMS; NITRIC OXIDE; SIGNAL TRANSDUCTION; TH1 CELLS;

EID: 85026517406     PISSN: 0393974X     EISSN: 17246083     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Theoharides TC, Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 2004; 25(5):235-41.
2. Reber LL, Sibilano R, Starkl P., et al. Imaging protective mast cells in living mice during severe contact hypersensitivity. JCI Insight 2017; 2(9). doi: 10.1172/jci.insight. 92900.
3. Taracanova A, Alevizos M, Karagkouni A., et al. SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors. Proc Natl Acad Sci USA 2017; 114(20):E4002-E4009. doi: 10.1073/pnas. 1524845114.
4. Dinarello CA. An expanding role for interleukin-1 blockade from gout to cancer. Mol Med 2014; 20(Suppl 1):S43-58. doi: 10.2119/molmed.2014.00232.
5. Carinci F, Lessiani G, Spinas E., Kritas SK, Ronconi G, Caraffa A, Conti P. Mast cell and cancer with special emphasis on il-37 an anti-inflammatory and inhibitor of innate immunity: new frontiers. J Biol Regul Homeost Agents 2016; 30(4):945-50.
6. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med 2012; 18(5):693-704. doi: 10.1038/nm.2755.
7. Galli SJ, Tsai M, Marichal T., Tchougounova E, Reber LL, Pejler G. Approaches for analyzing the roles of mast cells and their proteases in vivo. Adv Immunol 2015; 126:45-127. doi: 10.1016/bs.ai.2014.11.002.
8. Theoharides TC, Stewart JM, Taracanova A, Conti P., Zouboulis CC. Neuroendocrinology of the skin. Rev Endocr Metab Disord 2016; 17(3):287-94.
9. Galli SJ, Kalesnikoff J, Grimbaldeston M.A., Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005; 23:749-86.
10. Theoharides TC, Stewart JM, Tsilioni I. Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion. Int J Immunopathol Pharmacol 2017; 1:394632017707610. doi: 10.1177/0394632017707610.
11. Shaik-Dasthagirisaheb Y.B., Conti P. The role of mast cells in Alzheimer's disease. Adv Clin Exp Med 2016; 25(4):781-7. doi: 10.17219/acem/61914.
12. Powrie F, Menon S, Coffman RL Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993; 23(9):2223-29
13. Erratum in: Eur J Immunol 1994; 24(3):785.
14. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
15. Dinarello CA. Overview of the interleukin-1 family of ligands and receptors. Semin Immunol 2013; 25(6):389-93. doi: 10.1016/j.smim.2013.10.001.
16. Cavalli G, Koenders M, Kalabokis V., et al. Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation. Rheumatology (Oxford) 2016; 55(12):2220-29.
17. Conti P, Lessiani G, Kritas S.K., Ronconi G., Caraffa A, Theoharides TC. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition. Tissue Cell 2017 doi: 10.1016/j.tice.2017.04.002.
18. Conti P, Ronconi G, Caraffa A., Lessiani G, Duraisamy K. IL-37 a New IL-1 family member emerges as a key suppressor of asthma mediated by mast cells. Immunol Invest 2017; 46(3):239-50. doi: 10.1080/08820139.2016.1250220.